本页面由Tiger Trade Technology Pte. Ltd.提供服务

Praxis Precision Medicines, Inc.

310.38
-8.9000-2.79%
盘后310.380.00000.00%17:34 EDT
成交量:30.02万
成交额:9,387.00万
市值:86.44亿
市盈率:-23.03
高:321.94
开:308.97
低:308.51
收:319.28
52周最高:356.00
52周最低:26.70
股本:2,785.08万
流通股本:2,577.87万
量比:0.62
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-13.4758
每股收益(LYR):-13.4758
净资产收益率:-45.83%
总资产收益率:-28.69%
市净率:9.84
市盈率(LYR):-23.03

数据加载中...

2025/07/17

重要事件披露

Form 8-K - Current report
2025/06/27

重要事件披露

Form 8-K - Current report
2025/05/02

重要事件披露

Form 8-K - Current report
2025/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/02

重要事件披露

Form 8-K - Current report
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/28

重要事件披露

Form 8-K - Current report
2025/01/29

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]